Last updated on October 2017

Clostridium Difficile (C. diff) Vaccine

Brief description of study

Clostridium Difficile (C. diff) Vaccine

Detailed Study Description

A Phase 3, Placebo-controlled, Randomized, Observer-blinded Study to Evaluate the Efficacy, Safety, and Tolerability of a Clostridium Difficile Vaccine in Adults 50 Years of Age and Older

Clinical Study Identifier: TX153546

Contact Investigators or Research Sites near you

Start Over

Greta BonDurant

Central Kentucky Research Associates
Lexington, KY USA
  Connect »